title: Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.
authors.affiliation: Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0595, USA. kenneth.sherman@uc.edu
authors.forename: Kenneth E
authors.initials: KE
authors.lastname: Sherman
authors.forename: Russell
authors.initials: R
authors.lastname: Fleischer
authors.forename: Katherine
authors.initials: K
authors.lastname: Laessig
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Murray
authors.forename: William
authors.initials: W
authors.lastname: Tauber
authors.forename: Debra
authors.initials: D
authors.lastname: Birnkrant
mesh_terms: D026683:Advisory Committees; D000998:Antiviral Agents / Q000627:therapeutic use*; D017277:Drug Approval; D015507:Drugs, Investigational; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000998:Antiviral Agents; D015507:Drugs, Investigational